Zipalertinib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Zipalertinib, covering 2026-02-05 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection [Phase 3]